Group structure
6 companies in 4 countries
Loadingโฆ
6 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 75
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AZITHROMYCIN FOR INJECTION500 mg / vial ยท Powder For Solution | Azithromycin | Canada | Marketed | 2023 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial ยท Powder For Solution | Bortezomib | Canada | Authorised | |
| CLADRIBINE INJECTION1 mg / ml ยท Solution | Cladribine | Canada | Marketed | 2020 |
| DAUNORUBICIN INJECTABLE SOLUTION50 mg / 10 ml ยท Solution | Daunorubicin | Canada | Marketed | 2026 |
| DAUNORUBICIN INJECTABLE SOLUTION20 mg / 4 ml ยท Solution | Daunorubicin | Canada | Authorised | |
| FLUOROURACIL INJECTION5000 mg / 100 ml ยท Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION500 mg / 10 ml ยท Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION1000 mg / 20 ml ยท Solution | Fluorouracil | Canada | Authorised | |
| FLUOROURACIL INJECTION250 mg / 5 ml ยท Solution | Fluorouracil | Canada | Authorised | |
| GEMCITABINE FOR INJECTION USP200 mg / vial ยท Powder For Solution | Gemcitabine | Canada | Authorised | |
| GEMCITABINE FOR INJECTION USP1 g / vial ยท Powder For Solution | Gemcitabine | Canada | Authorised | |
| IRINOTECAN HYDROCHLORIDE INJECTION, USP20 mg / ml ยท Solution | Irinotecan | Canada | Marketed | 2024 |
| LEUCOVORIN CALCIUM INJECTION1000 mg / 100 ml ยท Solution | Calcium folinate | Canada | Marketed | 2021 |
| LEUCOVORIN CALCIUM INJECTION10 mg / ml ยท Solution | Calcium folinate | Canada | Marketed | 2019 |
| LEUCOVORIN CALCIUM INJECTION200 mg / 20 ml ยท Solution | Calcium folinate | Canada | Authorised | |
| MED-ANASTROZOLE1 mg ยท Tablet | Anastrozole | Canada | Not marketed | 2012 |
| MED-BICALUTAMIDE50 mg ยท Tablet | Bicalutamide | Canada | Authorised | |
| MED-BRIMONIDINE0.2 % / w/v ยท Solution | Brimonidine | Canada | Marketed | 2021 |
| MED-CLINDAMYCIN150 mg ยท Capsule | Clindamycin | Canada | Marketed | 2021 |
| MED-CLINDAMYCIN300 mg ยท Capsule | Clindamycin | Canada | Marketed | 2021 |
| MED-CYPROTERONE50 mg ยท Tablet | Cyproterone | Canada | Marketed | 2012 |
| MED-DORZOLAMIDE2 % / w/v ยท Solution | Dorzolamide | Canada | Marketed | 2023 |
| MED-DORZOLAMIDE-TIMOLOL20 mg / ml + 5 mg / ml ยท Solution | Dorzolamide, Timolol | Canada | Marketed | 2016 |
| MED-DUTASTERIDE0.5 mg ยท Capsule | Dutasteride | Canada | Not marketed | 2014 |
| MED-EXEMESTANE25 mg ยท Tablet | Exemestane | Canada | Marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 75 | 52 | 23 | CompaniesAll medicines |
Also in the registers of Italy, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: ยฉ OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybฤs ฤฏmonฤ Registrลณ centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence: Creative Commons Attribution
Report an error or request removalCorrections from the company itself are welcome.
Keep Partnersโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.